(STT) State Street - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US8574771031
Stock: Investment Servicing, Data Management, Trading, Investment Management
Total Rating 49
Risk 26
Buy Signal -0.23
| Risk 5d forecast | |
|---|---|
| Volatility | 27.4% |
| Relative Tail Risk | -0.38% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.45 |
| Alpha | 23.76 |
| Character TTM | |
|---|---|
| Beta | 1.205 |
| Beta Downside | 1.685 |
| Drawdowns 3y | |
|---|---|
| Max DD | 25.68% |
| CAGR/Max DD | 0.93 |
EPS (Earnings per Share)
Revenue
Description: STT State Street March 05, 2026
State Street Corporation (STT) provides financial services to institutional investors globally. Its core business involves asset servicing, including custody, accounting, and fund administration for diverse asset classes.
The company offers a broad suite of services. This includes back-office operations like recordkeeping and transaction management, as well as analytics for performance, risk, and compliance. Additionally, State Street provides trading services, such as foreign exchange and securities finance. The asset management and custody banking sector is characterized by high operational complexity and stringent regulatory requirements.
State Street also develops and licenses technology platforms like State Street Alpha, which integrates portfolio management, trading, and data aggregation tools. These platforms streamline investment processes for institutional clients. Investment management solutions, spanning various asset classes and product types like ETFs, are also a significant offering. This business model often involves long-term client relationships and recurring revenue streams.
State Street serves a wide range of institutional clients, including mutual funds, pension plans, insurance companies, and wealth managers. Further research on ValueRay can provide detailed financial metrics and competitive analysis.
Headlines to watch out for
- Global equity market performance impacts asset servicing fees
- Interest rate fluctuations affect net interest income
- Regulatory compliance costs pressure profit margins
- Competition from fintech firms erodes market share
- Foreign exchange volatility influences trading services revenue
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 2.94b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA 4.75 > 1.0 |
| NWC/Revenue: -1.08k% < 20% (prev -616.3%; Δ -467.3% < -1%) |
| CFO/TA 0.01 > 3% & CFO 3.31b > Net Income 2.94b |
| Net Debt (25.37b) to EBITDA (4.30b): 5.90 < 3 |
| Current Ratio: 0.20 > 1.5 & < 3 |
| Outstanding Shares: last quarter (284.8m) vs 12m ago -3.92% < -2% |
| Gross Margin: 67.21% > 18% (prev 0.58%; Δ 6.66k% > 0.5%) |
| Asset Turnover: 5.76% > 50% (prev 6.22%; Δ -0.46% > 0%) |
| Interest Coverage Ratio: 0.43 > 6 (EBITDA TTM 4.30b / Interest Expense TTM 8.68b) |
Altman Z'' -3.57
| A: -0.61 (Total Current Assets 54.70b - Total Current Liabilities 279.01b) / Total Assets 366.05b |
| B: 0.09 (Retained Earnings 31.39b / Total Assets 366.05b) |
| C: 0.01 (EBIT TTM 3.73b / Avg Total Assets 359.64b) |
| D: 0.09 (Book Value of Equity 30.85b / Total Liabilities 338.21b) |
| Altman-Z'' Score: -3.57 = D |
Beneish M 1.00
| DSRI: 9.69 (Receivables 43.25b/4.74b, Revenue 20.70b/21.97b) |
| GMI: 0.87 (GM 67.21% / 58.45%) |
| AQI: 1.42 (AQ_t 0.84 / AQ_t-1 0.59) |
| SGI: 0.94 (Revenue 20.70b / 21.97b) |
| TATA: -0.00 (NI 2.94b - CFO 3.31b) / TA 366.05b) |
| Beneish M-Score: 4.21 (Cap -4..+1) = D |
What is the price of STT shares?
As of March 14, 2026, the stock is trading at USD 126.00 with a total of 3,382,384 shares traded.
Over the past week, the price has changed by +0.25%, over one month by -5.18%, over three months by -5.28% and over the past year by +47.95%.
Over the past week, the price has changed by +0.25%, over one month by -5.18%, over three months by -5.28% and over the past year by +47.95%.
Is STT a buy, sell or hold?
State Street has received a consensus analysts rating of 3.69.
Therefor, it is recommend to hold STT.
- StrongBuy: 4
- Buy: 4
- Hold: 7
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the STT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 144.3 | 14.5% |
| Analysts Target Price | 144.3 | 14.5% |
STT Fundamental Data Overview March 12, 2026
P/E Trailing = 13.0372
P/E Forward = 10.4712
P/S = 2.4652
P/B = 1.3996
P/EG = 0.9189
Revenue TTM = 20.70b USD
EBIT TTM = 3.73b USD
EBITDA TTM = 4.30b USD
Long Term Debt = 25.14b USD (from longTermDebt, last quarter)
Short Term Debt = 4.66b USD (from shortTermDebt, last quarter)
Debt = 29.80b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 25.37b USD (from netDebt column, last quarter)
Enterprise Value = 13.73b USD (34.23b + Debt 29.80b - CCE 50.30b)
Interest Coverage Ratio = 0.43 (Ebit TTM 3.73b / Interest Expense TTM 8.68b)
EV/FCF = 5.03x (Enterprise Value 13.73b / FCF TTM 2.73b)
FCF Yield = 19.88% (FCF TTM 2.73b / Enterprise Value 13.73b)
FCF Margin = 13.18% (FCF TTM 2.73b / Revenue TTM 20.70b)
Net Margin = 14.23% (Net Income TTM 2.94b / Revenue TTM 20.70b)
Gross Margin = 67.21% ((Revenue TTM 20.70b - Cost of Revenue TTM 6.79b) / Revenue TTM)
Gross Margin QoQ = none% (prev 61.52%)
Tobins Q-Ratio = 0.04 (Enterprise Value 13.73b / Total Assets 366.05b)
Interest Expense / Debt = 6.53% (Interest Expense 1.95b / Debt 29.80b)
Taxrate = 18.63% (171.0m / 918.0m)
NOPAT = 3.04b (EBIT 3.73b * (1 - 18.63%))
Current Ratio = 0.20 (Total Current Assets 54.70b / Total Current Liabilities 279.01b)
Debt / Equity = 1.07 (Debt 29.80b / totalStockholderEquity, last quarter 27.84b)
Debt / EBITDA = 5.90 (Net Debt 25.37b / EBITDA 4.30b)
Debt / FCF = 9.30 (Net Debt 25.37b / FCF TTM 2.73b)
Total Stockholder Equity = 27.37b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.82% (Net Income 2.94b / Total Assets 366.05b)
RoE = 10.76% (Net Income TTM 2.94b / Total Stockholder Equity 27.37b)
RoCE = 7.10% (EBIT 3.73b / Capital Employed (Equity 27.37b + L.T.Debt 25.14b))
RoIC = 5.26% (NOPAT 3.04b / Invested Capital 57.76b)
WACC = 8.01% (E(34.23b)/V(64.03b) * Re(10.36%) + D(29.80b)/V(64.03b) * Rd(6.53%) * (1-Tc(0.19)))
Discount Rate = 10.36% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.21%
[DCF] Terminal Value 70.17% ; FCFF base≈2.73b ; Y1≈1.79b ; Y5≈817.4m
[DCF] Fair Price = N/A (negative equity: EV 15.95b - Net Debt 25.37b = -9.42b; debt exceeds intrinsic value)
EPS Correlation: 75.67 | EPS CAGR: 18.13% | SUE: 2.38 | # QB: 3
Revenue Correlation: 70.77 | Revenue CAGR: 4.64% | SUE: 2.61 | # QB: 3
EPS next Quarter (2026-06-30): EPS=2.95 | Chg7d=+0.014 | Chg30d=+0.007 | Revisions Net=+1 | Analysts=12
EPS current Year (2026-12-31): EPS=11.65 | Chg7d=+0.031 | Chg30d=+0.059 | Revisions Net=+2 | Growth EPS=+13.1% | Growth Revenue=+5.5%
EPS next Year (2027-12-31): EPS=13.02 | Chg7d=+0.028 | Chg30d=+0.035 | Revisions Net=+3 | Growth EPS=+11.8% | Growth Revenue=+4.3%
[Analyst] Revisions Ratio: +0.20 (3 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 2.7% (Discount Rate 10.4% - Earnings Yield 7.7%)
[Growth] Growth Spread = +3.4% (Analyst 6.0% - Implied 2.7%)
P/E Forward = 10.4712
P/S = 2.4652
P/B = 1.3996
P/EG = 0.9189
Revenue TTM = 20.70b USD
EBIT TTM = 3.73b USD
EBITDA TTM = 4.30b USD
Long Term Debt = 25.14b USD (from longTermDebt, last quarter)
Short Term Debt = 4.66b USD (from shortTermDebt, last quarter)
Debt = 29.80b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 25.37b USD (from netDebt column, last quarter)
Enterprise Value = 13.73b USD (34.23b + Debt 29.80b - CCE 50.30b)
Interest Coverage Ratio = 0.43 (Ebit TTM 3.73b / Interest Expense TTM 8.68b)
EV/FCF = 5.03x (Enterprise Value 13.73b / FCF TTM 2.73b)
FCF Yield = 19.88% (FCF TTM 2.73b / Enterprise Value 13.73b)
FCF Margin = 13.18% (FCF TTM 2.73b / Revenue TTM 20.70b)
Net Margin = 14.23% (Net Income TTM 2.94b / Revenue TTM 20.70b)
Gross Margin = 67.21% ((Revenue TTM 20.70b - Cost of Revenue TTM 6.79b) / Revenue TTM)
Gross Margin QoQ = none% (prev 61.52%)
Tobins Q-Ratio = 0.04 (Enterprise Value 13.73b / Total Assets 366.05b)
Interest Expense / Debt = 6.53% (Interest Expense 1.95b / Debt 29.80b)
Taxrate = 18.63% (171.0m / 918.0m)
NOPAT = 3.04b (EBIT 3.73b * (1 - 18.63%))
Current Ratio = 0.20 (Total Current Assets 54.70b / Total Current Liabilities 279.01b)
Debt / Equity = 1.07 (Debt 29.80b / totalStockholderEquity, last quarter 27.84b)
Debt / EBITDA = 5.90 (Net Debt 25.37b / EBITDA 4.30b)
Debt / FCF = 9.30 (Net Debt 25.37b / FCF TTM 2.73b)
Total Stockholder Equity = 27.37b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.82% (Net Income 2.94b / Total Assets 366.05b)
RoE = 10.76% (Net Income TTM 2.94b / Total Stockholder Equity 27.37b)
RoCE = 7.10% (EBIT 3.73b / Capital Employed (Equity 27.37b + L.T.Debt 25.14b))
RoIC = 5.26% (NOPAT 3.04b / Invested Capital 57.76b)
WACC = 8.01% (E(34.23b)/V(64.03b) * Re(10.36%) + D(29.80b)/V(64.03b) * Rd(6.53%) * (1-Tc(0.19)))
Discount Rate = 10.36% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.21%
[DCF] Terminal Value 70.17% ; FCFF base≈2.73b ; Y1≈1.79b ; Y5≈817.4m
[DCF] Fair Price = N/A (negative equity: EV 15.95b - Net Debt 25.37b = -9.42b; debt exceeds intrinsic value)
EPS Correlation: 75.67 | EPS CAGR: 18.13% | SUE: 2.38 | # QB: 3
Revenue Correlation: 70.77 | Revenue CAGR: 4.64% | SUE: 2.61 | # QB: 3
EPS next Quarter (2026-06-30): EPS=2.95 | Chg7d=+0.014 | Chg30d=+0.007 | Revisions Net=+1 | Analysts=12
EPS current Year (2026-12-31): EPS=11.65 | Chg7d=+0.031 | Chg30d=+0.059 | Revisions Net=+2 | Growth EPS=+13.1% | Growth Revenue=+5.5%
EPS next Year (2027-12-31): EPS=13.02 | Chg7d=+0.028 | Chg30d=+0.035 | Revisions Net=+3 | Growth EPS=+11.8% | Growth Revenue=+4.3%
[Analyst] Revisions Ratio: +0.20 (3 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 2.7% (Discount Rate 10.4% - Earnings Yield 7.7%)
[Growth] Growth Spread = +3.4% (Analyst 6.0% - Implied 2.7%)